0
Omeros Corporation
- 51-200 Employees
- Based in Seattle, Washington
Omeros Corporation, a biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. It markets Omidria for use during cataract surgery or intraocular lens, or replacement surgery.
Omeros Corporation
Most Recent Annual Report
MOST RECENT
2019 Annual Report and Form 10K
Report Locked. Omeros Corporation has reached its limit for free report views.
